IL21 and type 1 diabetes mellitus: JAK inhibitors were seen to block JAK-STAT downstream signaling cascades initiated by T1D-associated IFN-γ and γ chain cytokines, including IL-21 (Sutherland et al, 2013; Ge et al, 2020).